PPP1R3C and EFHD1 were selected and subsequently analyzed using plasma DNA samples of 120 CRC and 96 noncancer patients, using methylation-specific PCR in combination with pyrosequencing for validation of specific amplification of methylated DNA. This evidence concerns the gene EFHD1 and colorectal carcinoma.